Announcement PDF ASX Announcement 16 April 2024 Microba Launches Investor Hub for Investor Engagement Microba Life Sciences Limited (ASX: MAP) (“Microba” or the “Company”) has launched a new interactive Investor Hub for dedicated investor engagement, enabling Microba shareholders, stakeholders, and prospective investors to learn more about Microba’s activities and communicate with the Company’s leadership team directly. Microba invites shareholders and interested parties to join. How to join Microba’s new Investor Hub: 1. Visit https://ir.microba.com/welcome 2. Follow the prompts to sign up for an account. 3. Complete your account profile. Microba’s Chief Executive Officer, Dr Luke Reid, commented “We look forward to continuing to update investors in a more engaging environment through the new investor hub. The investor hub enables us to interact with our shareholders and the wider investor community in a more direct, transparent and frequent way. The platform enables people to ask questions and provide feedback on any of our ASX announcements or other updates, and engage in an open dialogue with management. This all supports the development of deeper relationships with our shareholders which is important to myself and the team as we grow Microba and together deliver a lasting impact on peoples’ lives across the globe.” Investors with complete Investor Hub accounts will be alerted to Microba’s news directly and may be invited to exclusive company events and corporate opportunities. To learn more, visit Microba’s Investor Hub at https://ir.microba.com/welcome This announcement has been authorised for release by the Chair and CEO. For further information, please contact: Dr Luke Reid Chief Executive Officer luke.reid@microba.com https://ir.microba.com/welcome About InvestorHub InvestorHub is an Australian-founded investor community platform that connects investors with companies and allows companies to build direct relationships with shareholders and investors. To find out more about InvestorHub visit www.investorhub.com About Microba Life Sciences Limited Microba Life Sciences is a precision microbiome company driven to improve human health. With world-leading technology for measuring the human gut microbiome, Microba is driving the discovery and development of novel therapeutics for major chronic diseases and delivering gut microbiome testing services globally to researchers, clinicians, and consumers. Through partnerships with leading organisations, Microba is powering the discovery of new relationships between the microbiome, health and disease for the development of new health solutions. For more information visit www.microba.com JOIN MICROBA’S INTERACTIVE INVESTOR HUB Visit ir.microba.com/welcome for Microba’s interactive Investor Hub Microba Life Sciences Ltd ABN 82 617 096 652 | 324 Queen Street, Brisbane QLD 4000 Australia | 1300 974 621